Pulse - Value AddedPulseValue Added
ACompany
← Library
Knowledge Library · Coaching
Powered by Pulse — Value Added. The #1 source of truth in revenue operations. Find the bottleneck. Fix the pipeline. Win the quarter.

Which part of your current pipeline has the highest risk of stalling, and what is your plan to move it forward in 2027?

pulserevops.com
✓
Quality
Certified
Which part of your current pipeline has the highest risk of stalling, and what is your plan to move it forward in 2027?
📖 2,876 words🗓️ Published Oct 1, 2026
Direct Answer

The highest-risk part of most current pipelines is the Active Evaluation stage, roughly 30–60% through the funnel, where buying committees of eight or more stakeholders stall on internal consensus rather than product fit. The plan to move it forward in 2027 is a three-step compression: weekly AI-flagged risk detection, stakeholder-blocker mapping, and a time-boxed Decision Week that forces a binary outcome within 14 days under RevOps ownership.

A Deal That Looks Healthy Until It Isn't

Picture a mid-market SaaS deal that cleared discovery in nine days, sailed through a well-received demo, and received pricing on schedule. Every early-stage metric says the deal is healthy. Then it enters Active Evaluation, and the calendar goes quiet. The champion still replies to emails, technical validation is signed off, and nobody has said no — but nobody has said yes either. Six weeks pass. This is the pattern that defines the highest-risk segment of a current pipeline: not the deals that get killed early, but the ones that go dormant in the middle, where committee size, internal politics, and procurement complexity compound faster than any single rep can track manually.

The reason this stage specifically carries the most risk is structural, not tactical. Early-stage deals fail fast and cheap — a bad-fit prospect disqualifies in days. Late-stage deals have legal and security teams actively working them, which creates forward motion even when it's slow. Active Evaluation sits in between: the deal has momentum but no forcing function. A champion can want to buy and still fail to get budget sign-off from a VP who was looped in two weeks after the demo. A security reviewer can sit on a ticket for three weeks because nobody owns escalating it. This is where pipeline value gets trapped — not lost, but stuck in a holding pattern that drains forecast accuracy and rep bandwidth simultaneously. The fix isn't more follow-up emails; it's a structured process that compresses the ambiguity committees create.

Which part of your current pipeline has the highest risk of stalling, and what is your plan to move it forward in 2027 — figure 1

How Committee Stalling Actually Happens

The mechanism behind a stall in this stage is rarely a single rejection — it's an accumulation of silent non-responses across a group that was never fully mapped in the first place. A rep typically has visibility into three or four people: the champion, maybe an economic buyer, maybe one technical evaluator. The other four to six people in the room — security, legal, a second budget approver, an end-user representative — are invisible in the CRM until they surface a blocking objection, usually late and usually without warning.

The practical breakdown works like this: engagement velocity — the count of stakeholder touches per week across email replies, call attendance, and portal or deck views — is the earliest honest signal of stall risk, because it moves before anyone announces a problem. When the number of active touches per week drops by half from its post-demo baseline, that is the leading indicator, not a missed close date. RevOps should treat a sustained velocity drop as the trigger for intervention, not a subjective "feels quiet" judgment call from the rep, because reps are structurally biased toward optimism about their own current pipeline.

Which part of your current pipeline has the highest risk of stalling, and what is your plan to move it forward in 2027 — figure 2

Once velocity drops, the next mechanical step is identifying which committee role went dark. A champion going quiet usually means they lost internal air cover and need help, not space. An economic buyer who never responds after pricing usually means budget wasn't actually confirmed at discovery — a qualification miss, not a late-stage problem. A procurement or security contact who appears only once, late, and then stalls is frequently the real blocker, because that role has veto power without urgency; a stalled security review costs them nothing personally while it costs the seller the entire deal. Mapping which of these three patterns is occurring determines which play to run next, and running the wrong play — pushing the champion harder when the real gap is an unconfirmed economic buyer — burns goodwill without addressing the actual stalling mechanism.

The Numbers That Separate a Stall From a Pause

Not every quiet week is a stall, and treating every pause as a crisis burns trust with legitimate committees that are simply working through procurement on their own timeline. The distinction has to be quantified, and three ranges are useful benchmarks for a current pipeline review.

First, dwell time. A deal that sits in Active Evaluation for 20–35 days after pricing is sent is within normal range for a mid-market deal with a five-to-eight-person committee; anything crossing 45–50 days without a scheduled next step is statistically more likely to be dead than delayed. Tracking median dwell time by segment (SMB vs. mid-market vs. enterprise) gives RevOps a baseline specific to the business rather than borrowing an industry figure that may not match actual deal complexity.

Which part of your current pipeline has the highest risk of stalling, and what is your plan to move it forward in 2027 — figure 3

Second, stakeholder coverage. If a rep has documented direct contact with fewer than half of the identified committee members by the time pricing goes out, the deal is structurally more exposed to a late surprise objection. A reasonable target is 60% direct engagement coverage before a deal is allowed to be forecast as "commit" — below that threshold, it stays in "best case" regardless of how warm the visible relationships feel, because the invisible half of the committee is where risk hides.

Third, touchpoint count and fatigue. Deals accumulate interactions — calls, emails, custom materials, security questionnaires — and each one adds friction for a committee that is also evaluating two or three competitors and running its own internal meetings. Past roughly 10–12 total touchpoints in Active Evaluation (excluding a planned final review), each additional ask measurably lowers the probability the committee converges, because it reads as the deal being unresolved rather than progressing. A practical ceiling policy — cap interactions, then force a structured final review once the ceiling is hit — keeps the deal from dying of a thousand well-intentioned follow-ups.

These three numbers, read together weekly, are what separates a RevOps-run risk process from a rep's gut feeling. A deal with low coverage, declining velocity, and rising touchpoint count without resolution is the clearest version of a pipeline stalling, and it should be flagged automatically rather than discovered at forecast review three weeks later.

Trade-Offs: Forcing a Decision vs. Letting It Breathe

Which part of your current pipeline has the highest risk of stalling, and what is your plan to move it forward in 2027 — figure 4

There is a real tension in this plan worth naming directly: forcing a binary decision within a fixed window can accelerate a loss just as easily as a win. Committees that are genuinely working through a complex internal process — multiple budget cycles, a merger, a hiring freeze — may need more than 14 days for reasons that have nothing to do with your deal's health, and an aggressive deadline can read as pressure tactics that damage the relationship permanently.

The trade-off resolves with a judgment gate, not a blanket rule: before triggering a forced Decision Week, RevOps or the rep should confirm whether the delay has an external, documented cause (a budget freeze, a reorg, an M&A event) versus an unexplained internal stall. A documented external cause earns an extension with a shorter re-check window — 30 days rather than the default 90-day recycle — because the deal is still alive, just paused by something outside the committee's control. An unexplained stall, by contrast, is exactly the scenario the forcing function exists for, because ambiguity is the actual enemy, not slowness itself.

The second trade-off is between automation and relationship cost. AI-driven risk scoring and engagement tracking are excellent for surfacing which deals need attention, but the re-engagement itself should stay human-written. Automated-feeling outreach to a stalled stakeholder reads as exactly what it is — a system noticing silence — and tends to lower response rates rather than raise them, because sophisticated buying committees in 2027 are accustomed to recognizing templated cadences. The right split is AI for detection and mapping, humans for every actual message sent to a stakeholder.

Which part of your current pipeline has the highest risk of stalling, and what is your plan to move it forward in 2027 — figure 5

The third trade-off is cost of process versus cost of inaction. Running a formal, multi-stakeholder Decision Week takes real coordination effort from the rep, the CRO or VP of Sales, and sometimes a subject-matter expert for compliance questions. That's expensive relative to just waiting. But the alternative — letting zombie deals sit in a current pipeline indefinitely — is more expensive in aggregate: it inflates forecast numbers that never close, it consumes SDR and AE attention that could go to active deals, and it delays the honest disqualification that frees up quota capacity. The math favors forcing clarity on any deal that has already shown two or more stall indicators, even though it costs more per deal in the short term.

Common Pitfalls in Running This Process

The first and most common mistake is treating every stage-stall the same way regardless of cause. A pricing objection disguised as committee silence is not the same problem as genuine internal gridlock, and applying the Decision Week forcing function to a pricing problem just produces a faster, cleaner "no" without ever surfacing the actual objection. Before escalating, confirm the economic buyer was identified and the value case was actually delivered to them directly — if that step was skipped, the fix is a conversation about value, not a deadline.

Which part of your current pipeline has the highest risk of stalling, and what is your plan to move it forward in 2027 — figure 6

The second pitfall is conflating "quiet" with "cold." A committee that has gone dark because they're waiting on an internal budget approval meeting that was already scheduled before your deal started is not stalling in the sense this process targets — it's progressing on its own calendar. Escalating too early on deals with a known, dated internal milestone wastes the forcing function's credibility and trains stakeholders to tune out your urgency signals on deals where it matters.

The third pitfall is running stakeholder mapping once and treating it as static. Committees change membership mid-evaluation more often than CRMs reflect — a new VP joins, a security lead rotates onto the account, a champion gets reassigned. A mapping done at the start of Active Evaluation and never refreshed will miss exactly the late-arriving blocker this process is designed to catch. Re-running the stakeholder check every one to two weeks, not once at deal entry, is what keeps the picture current.

The fourth pitfall is skipping the qualification audit before blaming the committee. If a deal stalls and the MEDDPICC review turns up a missing Economic Buyer, missing Decision Criteria, or an unconfirmed Decision Process, the honest read is that it was never properly advanced past discovery — it's not that the committee is being slow, it's that the deal was pushed forward without the groundwork to survive a real evaluation. A MEDDPICC audit run by RevOps, not sales, verifies all eight criteria: Metrics, Economic Buyer, Decision Criteria, Decision Process, Paper Process, Identify Pain, Champion, and Competition. If any of the 8 criteria are missing, the deal should be downgraded to Nurture rather than left inflating a current forecast it was never qualified to be in.

Which part of your current pipeline has the highest risk of stalling, and what is your plan to move it forward in 2027 — figure 7

The fifth pitfall is letting the 14-day Decision Week slide once it starts. The entire value of the forcing function comes from its firmness — a deadline that gets extended once will get requested again, and the deal reverts to exactly the ambiguous drift the process was built to eliminate. Extensions should be rare, documented, and tied to an external cause, never a default response to committee pushback.

Related questions

What's the difference between a stalled deal and a slow-moving one?

A slow deal has a visible next step and a dated reason for the pace — a scheduled budget meeting, a known procurement cycle. A stalled deal has no visible next step and declining stakeholder engagement with no explanation. The distinction determines whether you extend or escalate.

Who should own the Decision Week process — sales or RevOps?

RevOps should own the mechanics (triggering it, tracking criteria, running the audit) while the rep and their manager own the relationship conversations. Splitting ownership this way keeps the forcing function objective rather than tied to one rep's optimism about their own deal.

How early should stakeholder mapping start?

At the start of Active Evaluation, immediately after pricing is sent, not when a stall is already suspected. Mapping after the fact misses the stakeholders who were never visible, which is the exact group most likely to kill the deal.

Does this process apply the same way to enterprise and SMB deals?

Which part of your current pipeline has the highest risk of stalling, and what is your plan to move it forward in 2027 — figure 8

No — committee size and dwell-time benchmarks should scale with deal segment. An SMB deal with a two-person committee doesn't need a formal Decision Week; the forcing function earns its cost on deals complex enough to actually drift.

What happens to a deal that gets disqualified through this process?

It moves to a 90-day recycle queue (or 30 days if the cause was external and documented) rather than being deleted from the pipeline. A clean, timestamped "no" is more useful to forecasting than an indefinite "maybe."

FAQ

What if the committee asks for more time right at the end of the Decision Week? Evaluate whether the request comes with a specific, dated reason or is vague. A vague request for more time after a structured 14-day process has run is typically a soft no, and granting an open-ended extension usually just delays the same outcome by another quarter while consuming more pipeline capacity.

How do I know if a quiet stakeholder is a real blocker or just busy? Check engagement history, not assumptions. If they attended the demo and opened early materials but have gone silent since pricing, that's a signal worth a direct, low-pressure check-in. If they were never engaged at all, they're a mapping gap, not necessarily a blocker — the first step is simply making contact.

Which part of your current pipeline has the highest risk of stalling, and what is your plan to move it forward in 2027 — figure 9

Should every stalled deal get the full Decision Week treatment? No — reserve it for deals showing at least two risk indicators (declining velocity, low stakeholder coverage, or dwell time past your threshold). Running a heavy forcing function on every quiet deal burns the technique's effectiveness and annoys committees that are progressing normally.

What's the single highest-leverage fix for stalling in this stage? Mapping the full committee before pricing goes out, not after a stall is suspected. Most late-stage surprises come from a stakeholder who was never identified early enough to be engaged proactively.

Can this process work without AI-based engagement tracking tools? Yes, though it takes more manual discipline. A shared tracker logging stakeholder role, last contact date, and sentiment, reviewed weekly by RevOps, delivers most of the same signal — the tooling speeds detection, but the underlying discipline of mapping and forcing clarity is what actually moves deals.

How should this change the next quarter's forecasting process? Any deal failing the stakeholder-coverage or dwell-time threshold should be forecast at a lower confidence tier regardless of how the rep feels about it, and any deal that completes a Decision Week with a "Go" should move to a higher tier immediately, since it has just cleared the highest-risk point in the funnel.

Sources

flowchart TD S["Which part of your current pipeline ha"] S --> N0["A Deal That Looks Healthy Until It Isn"] N0 --> N1["How Committee Stalling Actually Happen"] N1 --> N2["The Numbers That Separate a Stall From"] N2 --> N3["Trade-Offs: Forcing a Decision vs. Let"]
flowchart LR C["Which part of your current pipeline ha"] C --> H0["How Committee Stalling Actually Happen"] C --> H1["The Numbers That Separate a Stall From"] C --> H2["Trade-Offs: Forcing a Decision vs. Let"] C --> H3["Common Pitfalls in Running This Proces"]

Related on PULSE

Download:
Was this helpful?  
LinkedIn · two-step paste
1 · Paste this first
Wait for the picture and card to appear, then delete this line — the card stays.
2 · Then paste this
No link to this page in here — the card is the link.
This page will be disappearing soon.
Download the whole page as a PDF to keep — just $1.
⌬ Apply this in PULSE
Pulse CheckScore reps on the metrics that matterGross Profit CalculatorModel margin per deal, per rep, per territory